Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dietressa in Obese Patients
NCT01535014Phase 3Completed
- Sponsor
- Materia Medica Holding
- Start
- Dec 2011
- Primary completion
- Jun 2013
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 3 trial of dietressa in obesity, sponsored by Materia Medica Holding. Started Dec 2011; status: completed.
02
Drugs
dietressa
03
Conditions
obesity
Beyond the preview
Go deeper on NCT01535014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01535014.